HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synchronous oesophageal carcinoma with non Hodgkin's lymphoma, problems with management.

Abstract
A case of synchronous malignancy of oesophagus with Non Hodgkin's lymphoma is presented and the rarity of such an association is discussed. The inherent difficulties encountered were initial planning of therapy keeping in view of the general condition of the patient. The patient received three cycles (every 21 days) of CHOP regimen for Non Hodgkin's lymphoma and to maintain a static state of oesophageal cancer. The patient showed more than 75 percent response to NHL counterpart, and for carcinoma oesophagus counterpart short course high dose loco-regional radiation therapy was given and the tumor was found to be resectable.
AuthorsV Ramesh, R K Tanwar, R Kaushal, G K Rath, A Vaid, V Pathak, R P Choubey
JournalIndian journal of cancer (Indian J Cancer) Vol. 33 Issue 3 Pg. 153-6 (Sep 1996) ISSN: 0019-509X [Print] India
PMID9055491 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Squamous Cell (diagnosis, therapy)
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Esophageal Neoplasms (diagnosis, therapy)
  • Humans
  • Laparotomy
  • Lymph Nodes (pathology)
  • Lymphoma, Non-Hodgkin (diagnosis, therapy)
  • Male
  • Middle Aged
  • Neoplasms, Multiple Primary (diagnosis, therapy)
  • Prednisolone (administration & dosage)
  • Radiotherapy Dosage
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: